Mass Polypeptide 2 Rescues Antigen Immunoproteasome Subunit Low Molecular Why the Structure but Not the Activity of the

Christopher Tsu and Marcus GroettrupReinhold Weber, Michael Przybylski, Alexei F. Kisselev, Michael Basler, Christoph Lauer, Jacqueline Moebius,http://www.jimmunol.org/content/189/4/1868doi: 10.4049/jimmunol.11035922012;J Immunol€2012; 189:1868-1877; Prepublished online 6 JulyReferenceshttp://www.jimmunol.org/content/189/4/1868.full#ref-list-1This article cites 48 articles, 28 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  P. Kloetzel,et al.  The Interferon-γ-inducible 11 S Regulator (PA28) and the LMP2/LMP7 Subunits Govern the Peptide Production by the 20 S Proteasome in Vitro(*) , 1995, The Journal of Biological Chemistry.

[2]  A. Goldberg,et al.  Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Tomoki Chiba,et al.  Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β , 2001 .

[4]  T. Soucy,et al.  Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit , 2010, The Biochemical journal.

[5]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[6]  K. Eichmann,et al.  Expression of housekeeping and immunoproteasome subunit genes is differentially regulated in positively and negatively selecting thymic stroma subsets , 2004, European journal of immunology.

[7]  P. Kloetzel,et al.  Overexpression of the Proteasome Subunits LMP2, LMP7, and MECL-1, But Not PA28α/β, Enhances the Presentation of an Immunodominant Lymphocytic Choriomeningitis Virus T Cell Epitope1 , 2000, The Journal of Immunology.

[8]  M. Groettrup,et al.  An Altered T Cell Repertoire in MECL-1-Deficient Mice1 , 2006, The Journal of Immunology.

[9]  M. van den Broek,et al.  Immunoproteasomes are essential for survival and expansion of T cells in virus‐infected mice , 2010, European journal of immunology.

[10]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[11]  M. Groettrup,et al.  Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.

[12]  J. Trowsdale,et al.  Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. , 1999, Journal of immunology.

[13]  B. Monsarrat,et al.  Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation1 , 2006, The Journal of Immunology.

[14]  L. Dick,et al.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.

[15]  A. Henn,et al.  Reduced Immunoproteasome Formation and Accumulation of Immunoproteasomal Precursors in the Brains of Lymphocytic Choriomeningitis Virus-Infected Mice , 2010, The Journal of Immunology.

[16]  Lance F. Barton,et al.  Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection1 , 2002, The Journal of Immunology.

[17]  M. Groettrup,et al.  Immunoproteasome-specific inhibitors and their application. , 2012, Methods in molecular biology.

[18]  C. Slaughter,et al.  The Proteasome, a Novel Protease Regulated by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[19]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[20]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[21]  P. Kloetzel,et al.  The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition , 2000 .

[22]  Marcus Groettrup,et al.  Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ , 1995, European journal of immunology.

[23]  Khalid W. Kalim,et al.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.

[24]  P. Kloetzel,et al.  Inactivation of a Defined Active Site in the Mouse 20S Proteasome Complex Enhances Major Histocompatibility Complex Class I Antigen Presentation of a Murine Cytomegalovirus Protein , 1998, The Journal of experimental medicine.

[25]  Peter M. Kloetzel,et al.  MHC Class I Antigen Processing of an Adenovirus CTL Epitope Is Linked to the Levels of Immunoproteasomes in Infected Cells1 , 2000, The Journal of Immunology.

[26]  B. Kessler,et al.  A novel cytosolic class I antigen‐processing pathway for endoplasmic‐reticulum‐targeted proteins , 2007, EMBO reports.

[27]  H. Overkleeft,et al.  A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. , 2007, Bioorganic & medicinal chemistry letters.

[28]  J. Shabanowitz,et al.  Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.

[29]  M. Probst-Kepper,et al.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. , 2000, Immunity.

[30]  Keiji Tanaka,et al.  Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes , 2007, Science.

[31]  F. Sallusto,et al.  Dendritic cells up‐regulate immunoproteasomes and the proteasome regulator PA28 during maturation , 1999, European journal of immunology.

[32]  H. Rammensee,et al.  Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.

[33]  A. Vitiello,et al.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.

[34]  D. Busch,et al.  Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Kasahara,et al.  Growth Retardation in Mice Lacking the Proteasome Activator PA28γ* , 1999, The Journal of Biological Chemistry.

[36]  Ricarda Schwab,et al.  Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity , 2012, Cell.

[37]  Matthew Britton,et al.  Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. , 2009, Chemistry & biology.

[38]  M. Groettrup,et al.  No essential role for tripeptidyl peptidase II for the processing of LCMV‐derived T cell epitopes , 2007, European journal of immunology.

[39]  Jonathan W. Yewdell,et al.  Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens , 2001, The Journal of experimental medicine.

[40]  K. Schwarz,et al.  Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why? , 2001 .

[41]  The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses1 , 2000, The Journal of Immunology.

[42]  D. Valmori,et al.  Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. , 2006, Cancer research.

[43]  Marcus Groettrup,et al.  The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection1 , 2009, The Journal of Immunology.

[44]  K. Schwarz,et al.  Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver1 , 2001, The Journal of Immunology.

[45]  M. Groettrup,et al.  The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity , 2011, The Journal of Immunology.

[46]  M. Groettrup,et al.  Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome , 2010, The Journal of Immunology.

[47]  V. Cerundolo,et al.  Role of Immunoproteasomes in Cross-Presentation1 , 2006, The Journal of Immunology.

[48]  Marcus Groettrup,et al.  Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1 , 2004, The Journal of Immunology.